Wednesday, September 14, 2011

H1N flu: the destruction of the vaccine against the rest completed by late November



PARIS - Vaccines against H1N1 pandemic influenza delivered during the 2009/2010 and unused, have been destroyed by the end of November, "according to the schedule ever," said Thierry Coudert Monday, the president of the organization responsible for managing inventory.

Of the 94 million doses ordered by the government, 44 million were delivered, the health minister at the time, Roselyne Bachelot, has canceled the rest of the commands.

Nearly 6 million people have been effectively vaccinated (one or two doses). 12.6 million doses have been given to the World Health Organization and 314,000 sold in Qatar, and Monaco.

Tuesday, September 13, 2011

Measles epidemic mainly affects South


Measles, a disease of children? Not only. Since 2008, a terrible epidemic in Europe, an epidemic that is important not to overlook, especially in the south of France, the region most affected. The alert is twofold. It is both the Academy of Medicine and Institute of Health Surveillance (InVS).
The Academy of Medicine, said that "more than 20 000 cases were reported since 2008" in France, where 2011 was a year marked by a real outbreak. Of these 20,000 cases, "14,000 were reported between January and June 2011." For its part, the Institute of Public Health said that over the past seven months, "fifteen of the cases had a neurological complication, 639 severe pneumonia and six died."

intervenMediator: Servier would have ed to correct a Senate report


Servier Laboratories intervened in June a Senate report on the Ombudsman minimizes liability and insists that the drug agency, said on Tuesday, September 13, Le Figaro, citing excerpts from wiretaps placed on the register test. The report's author, Sen. Maria Teresa Hermange UMP, has categorically denied these claims.

Have tapped a conversation between the group's operations director Servier, Jean-Philippe Seta, and Claude Griscelli, a former member of the Council of State, Professor of Pediatrics and Genetics, former Director General of Inserm. M. Griscelli Servier leader said as speaker of the Senate Hermange, the madam, "asked to

Monday, September 12, 2011

Botulism: three victims of contaminated complain tapenade


The first three of the eight complaints from victims of contaminated tapenade made ​​by the company La Ruche in Cavaillon (Vaucluse) were recorded on the morning of Tuesday in the Superior Court of Amiens (Somme).

On the same subject

      All products of the hive bee products rappelésL'ensemble recalled

      Botulism: After "Las Delicias de Marie Claire", another brand under surveillance
      Botulism: the set of beehive products recalled

Sunday, September 11, 2011

Exceeded rates of physicians: the state pushed to act


Scalded by the tax on mutual complementary health withdrew from the negotiations on the management of excess fees for physicians. The ball is in the courtyard of the executive, who wanted to solve the problem before the presidential election.Written byA few months before the presidential election, the executive hopes to get credit for a breakthrough in the delicate question of the higher fees of private practitioners. This hope was away this week, refusing to negotiate on this health issue. The Unocam, representing the families of three complementary (mutual insurance companies, pension funds) officially ended talks today. One way to protest against increasing the tax burden on them, which has been approved by Parliament.

Saturday, September 10, 2011

In 2010, the French have paid out of pocket spending by 9.4% in health


Health spending in France has reached 234.1 billion in 2010, three-quarters funded by Social Security, 13.5% of the bodies and more than 9.4% by the patients themselves.

As was the case in 2009, the unpaid portion of health spending declined slightly in 2010, according to the latest edition of "Health Accounts" published on Wednesday.

Friday, September 9, 2011

The Servier Protelos be reviewed


The risk / benefit of Protelos, an osteoporosis drug Servier, be reviewed at the Commission authorization to market Sept. 29 because of "persistent and significant, serious side effects."
129 "serious adverse events" were recorded 3.3 million cases sold from April 2009 to March 2011, according to a report presented yesterday to the Technical Committee on Pharmacovigilance (CTPV). Following this meeting, the European Agency for Health Product Safety (AFSSAPS) decided to review the Commission's benefit / risk MA on September 29, said today.

Thursday, September 8, 2011

The mediator will sow disorder in politics


The Senate report has been reviewed by Servier address? Leaks, published yesterday suggest. The crazy lab. But the shadow of conflict of interest flat again.Marie-Christine Blandin (Europe Ecology - The Greens) does not hide his displeasure. Senator North, a member of the parliamentary information mission of the mediator ", if we change one or more sentences of our report on Servier is severe. During the trial, we know that lawyers can use the laboratory of our work and say, ' Look, even the parliament have written this or that '. "

Wednesday, September 7, 2011

Fluorescent Cats to advance AIDS research

SCIENCE - Cats are some of the "sensitive" animals with HIV ...
The experiment was conducted in pigs, rabbits, mice and Drosophila melanogaster (fruit fly known as vinegar). An American scientist, Eric Poeschl, of the Mayo Clinic in Rochester (Minnesota), has produced three cats this time genetically engineered fluorescent domiestiques. According to their findings, published in the journal Nature Methods, the animals could advance research on AIDS.The fluorescent protein can serve as a marker
How does an animal a fluorescent? Green fluorescent protein (GFP) was discovered in 1962 by chemist Osamu Shimomura, trying to isolate the pigments from the bioluminescent jellyfish Aequorea victoria. This protein becomes slightly greenish light as soon as exposed to sunlight, under a yellow light bulb and fluorescent green under a UV lamp.
The gene for this protein can be fused with other genes and reintroduced into cells or an embryo, which will then be synthesized. "By connecting GFP-protein easily detectable by their green fluorescence of these proteins to a cell, researchers can now follow their behavior, movements and interactions with the environment of the cell," explains an article from the site of culture chemical science.
>> For more information on green fluorescent protein, click hereA method that would develop research
Scientists hope to use these genetically modified cats for the study of HIV, reports the Guardian.
"Cats are susceptible to human immunodeficiency virus (FIV), similar to HIV, the cause of AIDS," said Professor Helen Sang and Bruce Whitelaw, Roslin Institute of Edinburgh University, where he was the first cloned sheep, Dolly in 1996.
Dr. Robin Lovell-Badge, which is at the head of the Department of National Development Genetics Medical Research Institute Medical Research Council, said: "Cats are one of the few species that are sensitive to this type of virus, and therefore an object of a pandemic, with such devastating symptoms for cats than for humans. "

Tuesday, September 6, 2011

A high performance scanner opened at the Museum


The skulls of prehistoric humans, insects, meteorites ... Nothing should stand AST-RX, a new scanner for advanced exploration of 3D objects in the natural sciences. In tests since last May, this tool worth € 876,000 opened yesterday at the National Museum of Natural History (5th).

Monday, September 5, 2011

A measure supported prostate cancer


Treatment of prostate cancer is more tailored, say experts on the seventh day of the prostate of the French Association of Urology (AFU), held today. Fits "tumor characteristics (size, aggressiveness), the life expectancy of the patient and her choice of life (sexuality)," says Professor Pascal Rischmann (CHU de Toulouse). This is the most common male cancer (71,500 new cases per year). It is the second leading cause of death in men for cancer, after lung, but the first years after age 50, according to the AFU. It affects one in every six men between 60 and 79. This day is an opportunity for the EBA (www.urofrance.org) to inform about the different ways of treating this disease that is causing about 9,000 deaths a year. Council EBA: check 55 years to 69 years from 45 years in cases such as family history of cancer.
"A mosaic of cancer"